Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenue:
Licensing revenue
Expenses:
Research and development	28,808	30,296
General and administrative	690,852	801,601
Loss from operations	(719,660)	(831,897)
Other income:
Interest income	369	18,632
Royalty and milestone rights		1,000,000
Net income (loss)	$ (719,291)	$ 186,735
Total basic income (loss) per share	$ (1.45)	$ 0.38
Total diluted income (loss) per share	$ (1.45)	$ 0.38
Basic weighted average shares outstanding	495,092	495,092
Diluted weighted average shares outstanding	495,092	495,092